Wall Street Analysts See a 40.85% Upside in BeiGene (BGNE): Can the Stock Really Move This High?

Shares of BeiGene, Ltd. (BGNE) have gained 20.1% over the past four weeks to close the last trading session at $182.76, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $257.41 indicates a potential upside of 40.9%.The mean estimate comprises 11 short-term price targets with a standard deviation of $56.75. While the lowest estimate of $161 indicates a 11.9% decline from the curre ...